Leap Therapeutics Inc.

NAS: LPTX

GO
/marketstate/country/us

Before the Bell

/zigman2/quotes/208240414/composite

$

1.24

Change

+0.03 +2.48%

Volume

Volume 27,150

Jun 27, 2022, 7:46 a.m.

Real time quotes

/zigman2/quotes/208240414/composite

Previous close

$ 1.21

$ 1.21

Change

-0.02 -1.63%

Day low

Day high

$1.11

$1.35

Open
Open: 1.24

52 week low

52 week high

$0.92

$4.17

Open

Market cap

$106.87M

Average volume

839,649

P/E ratio

N/A

Rev. per Employee

$41,667

EPS

-0.48

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/lptx

MarketWatch News on LPTX

  1. Leap Therapeutics started at buy with $6 stock price target at Mizuho

    6:34 a.m. Oct. 4, 2021

    - Tomi Kilgore

  2. Leap Therapeutics downgraded to market perform from outperform at Raymond James

    9:25 a.m. Nov. 15, 2019

    - Tomi Kilgore

  3. Leap Therapeutics stock price target cut to $8 from $13 at Raymond James

    9:57 a.m. Dec. 19, 2018

    - Tomi Kilgore

  4. Leap Therapeutics started at buy with $18 stock price target at Ladenburg Thalmann

    8:51 a.m. March 7, 2017

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/lptx

Other News on LPTX

  1. Bristol Myers' (BMY) Breyanzi sBLA Receives EMA Validation

    10:32 a.m. June 21, 2022

    - Zacks.com

  2. Seagen (SGEN) Stock Up on Rumors of Acquisition by Merck

    12:19 p.m. June 20, 2022

    - Zacks.com

  3. FDA Panel Votes Against Acadia (ACAD) sNDA for Nuplazid

    11:27 a.m. June 20, 2022

    - Zacks.com

  4. Alnylam's (ALNY) Rare Disease Drug, Amvuttra, Gets FDA Nod

    11:12 a.m. June 14, 2022

    - Zacks.com

  5. Global Blood's (GBT) Candidates for SCD Get Two FDA Tags

    11:23 a.m. June 7, 2022

    - Zacks.com

  6. Loading more headlines...
/news/pressrelease/company/us/lptx

Press Releases on LPTX

  1. Leap Therapeutics to Host Virtual R&D Day on July 12, 2022

    50 min ago

    - PR Newswire - PRF

  2. Leap Therapeutics Reports First Quarter 2022 Financial Results

    7:00 a.m. May 13, 2022

    - PR Newswire - PRF

  3. Leap Therapeutics Reports Third Quarter 2021 Financial Results

    8:00 a.m. Nov. 12, 2021

    - PR Newswire - PRF

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.